Researcher Tweaks 2009 Pandemic Flu Virus to Make It More Lethal

Global Security Newswire Staff
Add to Briefcase
Global Security Newswire Staff
July 3, 2014, 9:03 a.m.

A re­search­er has mod­i­fied the 2009 pan­dem­ic flu vir­us to al­low it to evade the an­ti­bod­ies that hu­mans have de­veloped against it.

Uni­versity of Wis­con­sin-Madis­on sci­ent­ist Yoshi­hiro Kawaoka has slightly altered the ge­net­ic makeup of the H1N1 in­flu­enza strain in or­der to en­able it to break free of the im­mune sys­tem re­sponses that hu­mans have de­veloped to­ward the vir­us in re­cent years, the Lon­don Daily Tele­graph re­por­ted on Wed­nes­day.

Kawaoka has not yet pub­lished his re­search but said it is ready to be sub­mit­ted to a sci­entif­ic journ­al.

“Through se­lec­tion of im­mune es­cape vir­uses in the labor­at­ory un­der ap­pro­pri­ate con­tain­ment con­di­tions, we were able to identi­fy the key re­gions [that] would en­able 2009 H1N1 vir­uses to es­cape im­munity,” the re­search­er wrote in an email.

Kawaoka has car­ried out a num­ber of con­tro­ver­sial stud­ies in­volving flu vir­uses. He led a team of re­search­ers at the Uni­versity of Wis­con­sin in re­pro­du­cing nearly the en­tire vir­us that caused the deadly 1918 Span­ish flu out­break. He also con­duc­ted a study that mod­i­fied the H5N1 vir­us to make it more eas­ily trans­fer­rable between mam­mals.

The flu spe­cial­ist’s most re­cent re­search was ap­proved by Wis­con­sin’s In­sti­tu­tion­al Biosafety Com­mit­tee. Re­becca Mor­itz, who is tasked with mon­it­or­ing re­search in the state done on “se­lect agents,” said Kawaoka’s work on the H1N1 flu strain would in­form un­der­stand­ing about how the vir­us could mutate in the fu­ture, pos­sibly mak­ing cur­rent vac­cines in­ef­fect­ive.

“This work is not to cre­ate a new strain of in­flu­enza with pan­dem­ic po­ten­tial, but [to] mod­el the im­mune-pres­sure the vir­us is cur­rently fa­cing in our bod­ies to es­cape our de­fenses,” she said.

Kawaoka ac­know­ledged the safety con­cerns about his re­search but said, “There are risks in all re­search. … As for all the re­search on in­flu­enza vir­uses in my labor­at­ory, this work is per­formed by ex­per­i­enced re­search­ers un­der ap­pro­pri­ate con­tain­ment and with full re­view and pri­or ap­prov­al by the [biosafety com­mit­tee].”

What We're Following See More »
SANS PROOF
NRA Chief: Leftist Protesters Are Paid
2 days ago
UPDATE
NEW TRAVEL BAN COMING SOON
Trump Still on Campaign Rhetoric
2 days ago
UPDATE
“WE’RE CHANGING IT”
Trump Rails On Obamacare
2 days ago
UPDATE

After spending a few minutes re-litigating the Democratic primary, Donald Trump turned his focus to Obamacare. “I inherited a mess, believe me. We also inherited a failed healthcare law that threatens our medical system with absolute and total catastrophe” he said. “I’ve been watching and nobody says it, but Obamacare doesn’t work.” He finished, "so we're going to repeal and replace Obamacare."

FAKE NEWS
Trump Goes After The Media
2 days ago
UPDATE

Donald Trump lobbed his first attack at the “dishonest media” about a minute into his speech, saying that the media would not appropriately cover the standing ovation that he received. “We are fighting the fake news,” he said, before doubling down on his previous claim that the press is “the enemy of the people." However, he made a distinction, saying that he doesn't think all media is the enemy, just the "fake news."

FBI TURNED DOWN REQUEST
Report: Trump Asked FBI to Deny Russia Stories
2 days ago
THE LATEST

"The FBI rejected a recent White House request to publicly knock down media reports about communications between Donald Trump's associates and Russians known to US intelligence during the 2016 presidential campaign, multiple US officials briefed on the matter tell CNN. But a White House official said late Thursday that the request was only made after the FBI indicated to the White House it did not believe the reporting to be accurate."

Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login